Thirdly, as the distinct roles of ARG1 and ARG2 in the pathogenesis of DM and its complications, developing isoform-specific arginase inhibitors is a novel strategy to improve the therapeutic efficacy. This evidence concerns the gene ARG2 and diabetes mellitus.